Home > Insider Trading > Filing (0001209191-19-009663)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242825	M Jeffrey Leiden	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Ceo & President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-02-11	14,707	$179.28	223,916	No	4	S	Direct
Common Stock	Disposition	2019-02-11	47,661	$179.93	176,255	No	4	S	Direct
Common Stock	Disposition	2019-02-11	48,651	$180.81	127,604	No	4	S	Direct
Common Stock	Disposition	2019-02-11	412	$181.80	127,192	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	440	Indirect	401(k)

Footnotes

Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $179.28 (range $178.47 to $179.47).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $179.93 (range $179.48 to $180.47).
Open market sales reported on this line occurred at a weighted average price of $180.81 (range $180.48 to $181.45).
Open market sales reported on this line occurred at a weighted average price of $181.80 (range $181.52 to $181.81).